Background: Nasopharyngeal carcinoma (NPC) is uncommon in the Western hemisphere
and in Europe. The undifferentiated subtype has a relevant propensity to metastasize …

Original research study Chemotherapy plus radiotherapy makes curability a possibility in
nasopharyngeal carcinoma patients wit Page 1 Original research study Licensee OA …

Background We designed this retrospective study to explore the best treatment modality for
patients with initially metastatic nasopharyngeal carcinoma (NPC). Methods From 2008 to …

Chemotherapy is the current mainstay of treatment for patients with newly diagnosed
metastatic nasopharyngeal carcinoma (NPC), whereas the role of locoregional radiotherapy …

Objectives To investigate the efficacy of high-dose radiation therapy (RT) to the primary and
regional disease in combination with systemic chemotherapy and local treatment to …

BACKGROUND: The current retrospective study aimed to identify some determinants of
survival in metastatic NPC. METHODS: The study concerned 95 patients with metastatic …

Background The role of locoregional radiotherapy in patients with primary metastatic
nasopharyngeal carcinoma (mNPC) is unclear. Methods In our open-label, phase 3, multi …

The outcome of locoregionally advanced nasopharyngeal carcinoma (NPC) remains
unsatisfactory due to high rates of local and distant failure, and the best way of integration of …

Background To review the treatment outcomes of patients presenting to Memorial Sloan‐
Kettering Cancer Center with metastatic nasopharyngeal carcinoma. Methods From April …

Background Immunochemotherapy has become the first‐line treatment for initial diagnosed
metastatic nasopharyngeal carcinoma (mNPC). Loco‐regional radiotherapy combined with …